Life Sciences

MassBio reported in its 2022 industry snapshot that Worcester County experienced 20.4% growth in biomanufacturing jobs and 19.4% research and development jobs between 2020 and 2021.

Framingham-based medical alert company, Lifeline Systems Co., has leased 40,000 square feet of office space at 200 Donald Lynch Blvd. in Marlborough, filling the last unoccupied space in the 116,786 square-foot office building.

When Shacey Petrovic stepped down as CEO of Acton medical-device company Insulet in May for personal reasons, she left Central Massachusetts without a single public company headquartered here, traded on NASDAQ or New York Stock Exchange, with a woman as CEO.

The U.S. Food and Drug Administration has cleared an insulin delivery system from Acton medical device firm Insulet Corp. for children two years and older with type 1 diabetes.

Franklin medical-device manufacturer Tegra Medical is expanding its Costa Rican operations with the purchase of a new 85,000-square-foot building.

Avenge Bio, Inc., a Natick biotechnology company, announced on Monday that a paper has been published on the efficacy of its LOCOcyte immunotherapy platform, which is used to administer treatments to solid tumors.

Central Massachusetts is brimming with young talent, as scores of people have achieved much in a relatively short period of time, while scores more have the potential to do great things.

A German biopharmaceutical manufacturing company has shifted its governance structure and hired an industry veteran as its new vice president and top executive at its Milford facility. 

New York City-based The Lightstone Group, with its partner Outshine Properties, has purchased 100-150 Staples Drive in Framingham for $24.7 million, which is more than double the price the property sold for in 2021.

Trelleborg Healthcare and Medical of Minnesota, a subsidiary of engineering giant Trelleborg AB of Sweden, will expand its manufacturing facility and BioPharma Center of Excellence in Northborough.